Hims & Hers Health, Inc.

HIMSNYSEUSD
30.25 USD
0.42 (1.39%)🟢PRE MARKET (AS OF 06:00 AM EDT)
🟢Market: OPEN

HIMS is currently priced at $30.25. Our models show a "Neutral" technical signal alongside a "Sell" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, HIMS trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 26, 2026.

Open?$30.09
High?$30.52
Low?$30.07
Prev. Close?$29.83
Volume?77.5K
Avg. Volume?14.6M
VWAP?$30.28
Rel. Volume?0.01x
Bid / Ask
Bid?$30.21 × 300
Ask?$30.30 × 100
Spread?$0.09
Midpoint?$30.26
Valuation & Ratios
Market Cap?7.0B
Shares Out?224.9M
Float?194.6M
Float %?87.4%
P/E Ratio?N/A
P/B Ratio?15.60
EPS?-$0.06
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Employees
2.4K
Market Cap
7.0B
Industry
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Listed
2021-01-21
Address
2269 CHESTNUT ST
SAN FRANCISCO, CA 94123
Phone: 415-851-0195
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
98
Momentum?
5
Short Sent.?
28
Piotroski F-Score?2/9Weak
Altman Z-Score?4.86Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?30.15%Squeeze Risk
Short Interest?58.7M
Days to Cover?4.5
Free Float194.6M
Avg Daily Volume13.1M
Settlement Date2026-08-14
Financial Health
Current Ratio?1.69Adequate
Quick Ratio?1.56Adequate
Cash Ratio?0.36Low
Debt/Equity?2.18High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
53/100
P/E?
N/A
P/B?
Peers
100
S&P
11
15.60HIGH
P/S?
Peers
100
S&P
51
2.94CHEAP
P/FCF?
Peers
100
S&P
3
104.1PRICEY
EV/EBITDA?
Peers
100
S&P
3
205.3HIGH
EV/Sales?
Peers
100
S&P
57
3.25FAIR
Returns & Efficiency
ROE?
S&P
13
-3.0%WEAK
ROA?
S&P
6
-0.6%WEAK
Cash Flow & Enterprise
FCF?$66.9M
Enterprise Value?$7.7B
Fundamentals ratios updated end of day